Canada · Delayed Price · Currency is CAD Extendicare Statistics
Total Valuation
Extendicare has a market cap or net worth of CAD 2.90 billion. The enterprise value is 3.46 billion.
| Market Cap | 2.90B |
| Enterprise Value | 3.46B |
Important Dates
The last earnings date was Thursday, August 6, 2026.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | Aug 31, 2026 |
Share Statistics
Extendicare has 95.05 million shares outstanding. The number of shares has increased by 2.00% in one year.
| Current Share Class | 95.05M |
| Shares Outstanding | 95.05M |
| Shares Change (YoY) | +2.00% |
| Shares Change (QoQ) | +0.03% |
| Owned by Insiders (%) | 1.25% |
| Owned by Institutions (%) | 34.71% |
| Float | 93.86M |
Valuation Ratios
The trailing PE ratio is 23.25 and the forward PE ratio is 19.88.
| PE Ratio | 23.25 |
| Forward PE | 19.88 |
| PS Ratio | 1.47 |
| PB Ratio | 7.17 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 29.54 |
| P/OCF Ratio | 19.78 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.12, with an EV/FCF ratio of 35.16.
| EV / Earnings | 28.50 |
| EV / Sales | 1.75 |
| EV / EBITDA | 16.12 |
| EV / EBIT | 19.46 |
| EV / FCF | 35.16 |
Financial Position
The company has a current ratio of 0.75, with a Debt / Equity ratio of 1.60.
| Current Ratio | 0.75 |
| Quick Ratio | 0.66 |
| Debt / Equity | 1.60 |
| Debt / EBITDA | 3.05 |
| Debt / FCF | 6.57 |
| Interest Coverage | 7.35 |
Financial Efficiency
Return on equity (ROE) is 43.81% and return on invested capital (ROIC) is 19.95%.
| Return on Equity (ROE) | 43.81% |
| Return on Assets (ROA) | 9.37% |
| Return on Invested Capital (ROIC) | 19.95% |
| Return on Capital Employed (ROCE) | 14.93% |
| Weighted Average Cost of Capital (WACC) | 9.19% |
| Revenue Per Employee | 84,195 |
| Profits Per Employee | 5,161 |
| Employee Count | 23,500 |
| Asset Turnover | 1.70 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Extendicare has paid 35.87 million in taxes.
| Income Tax | 35.87M |
| Effective Tax Rate | 22.83% |
Stock Price Statistics
The stock price has increased by +130.17% in the last 52 weeks. The beta is 1.15, so Extendicare's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | +130.17% |
| 50-Day Moving Average | 35.02 |
| 200-Day Moving Average | 27.91 |
| Relative Strength Index (RSI) | 27.97 |
| Average Volume (20 Days) | 631,572 |
Short Selling Information
The latest short interest is 1.59 million, so 1.90% of the outstanding shares have been sold short.
| Short Interest | 1.59M |
| Short Previous Month | 1.60M |
| Short % of Shares Out | 1.90% |
| Short % of Float | 2.22% |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Extendicare had revenue of CAD 1.98 billion and earned 121.28 million in profits. Earnings per share was 1.31.
| Revenue | 1.98B |
| Gross Profit | 286.85M |
| Operating Income | 175.02M |
| Pretax Income | 157.15M |
| Net Income | 121.28M |
| EBITDA | 207.46M |
| EBIT | 175.02M |
| Earnings Per Share (EPS) | 1.31 |
Balance Sheet
The company has 93.47 million in cash and 645.75 million in debt, with a net cash position of -552.28 million or -5.81 per share.
| Cash & Cash Equivalents | 93.47M |
| Total Debt | 645.75M |
| Net Cash | -552.28M |
| Net Cash Per Share | -5.81 |
| Equity (Book Value) | 404.77M |
| Book Value Per Share | 4.26 |
| Working Capital | -94.49M |
Cash Flow
In the last 12 months, operating cash flow was 146.77 million and capital expenditures -48.49 million, giving a free cash flow of 98.28 million.
| Operating Cash Flow | 146.77M |
| Capital Expenditures | -48.49M |
| Depreciation & Amortization | 32.44M |
| Net Borrowing | 337.29M |
| Free Cash Flow | 98.28M |
| FCF Per Share | 1.03 |
Margins
Gross margin is 14.50%, with operating and profit margins of 8.85% and 6.13%.
| Gross Margin | 14.50% |
| Operating Margin | 8.85% |
| Pretax Margin | 7.94% |
| Profit Margin | 6.13% |
| EBITDA Margin | 10.49% |
| EBIT Margin | 8.85% |
| FCF Margin | 4.97% |
Dividends & Yields
This stock pays an annual dividend of 0.53, which amounts to a dividend yield of 1.74%.
| Dividend Per Share | 0.53 |
| Dividend Yield | 1.74% |
| Dividend Growth (YoY) | 5.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 40.28% |
| Buyback Yield | -2.00% |
| Shareholder Yield | -0.27% |
| Earnings Yield | 4.18% |
| FCF Yield | 3.38% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Extendicare is 39.83, which is 31.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 39.83 |
| Price Target Difference | 31.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 16.54% |
| EPS Growth Forecast (3Y) | 18.64% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Extendicare has an Altman Z-Score of 2.38 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.38 |
| Piotroski F-Score | 5 |